AAAAAA

   
Results: 1-8 |
Results: 8
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Authors: Eiermann, W Paepke, S Appfelstaedt, J Llombart-Cussac, A Eremin, J Vinholes, J Mauriac, L Ellis, M Lassus, M Chaudri-Ross, HA Dugan, M Borgs, M Semiglazov, V
Citation: W. Eiermann et al., Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study, ANN ONCOL, 12(11), 2001, pp. 1527-1532
Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data
Authors: Eiermann, W
Citation: W. Eiermann, Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data, ANN ONCOL, 12, 2001, pp. 57-62
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: A randomized, controlled, open phase IIb study
Authors: von Minckwitz, G Costa, SD Raab, G Blohmer, JU Eidtmann, H Hilfrich, J Merkle, E Jackisch, C Gademann, G Tulusan, AH Eiermann, W Graf, E Kaufmann, M
Citation: G. Von Minckwitz et al., Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: A randomized, controlled, open phase IIb study, J CL ONCOL, 19(15), 2001, pp. 3506-3515
Predictive relevance of soluble CD44v6 serum levels for the responsivenessto second line hormone- or chemotherapy in patients with metastatic breastcancer
Authors: Kopp, R Classen, S Wolf, H Gholam, P Possinger, K Eiermann, W Wilmanns, W
Citation: R. Kopp et al., Predictive relevance of soluble CD44v6 serum levels for the responsivenessto second line hormone- or chemotherapy in patients with metastatic breastcancer, ANTICANC R, 21(4B), 2001, pp. 2995-3000
Use of chemotherapy plus a monoclonal antibody against HER2 for metastaticbreast cancer that overexpresses HER2.
Authors: Slamon, DJ Leyland-Jones, B Shak, S Fuchs, H Paton, V Bajamonde, A Fleming, T Eiermann, W Wolter, J Pegram, M Baselga, J Norton, L
Citation: Dj. Slamon et al., Use of chemotherapy plus a monoclonal antibody against HER2 for metastaticbreast cancer that overexpresses HER2., N ENG J MED, 344(11), 2001, pp. 783-792
Herceptin, a new treatment for breast cancer
Authors: Raab, G Eiermann, W
Citation: G. Raab et W. Eiermann, Herceptin, a new treatment for breast cancer, INTERNIST, 42(6), 2001, pp. 835
Primary systemic therapy for breast cancer
Authors: Eiermann, W
Citation: W. Eiermann, Primary systemic therapy for breast cancer, ONKOLOGIE, 22, 1999, pp. 14-15
Preoperative chemotherapy in breast cancer
Authors: von Minckwitz, G Costa, SD Blohmer, J Eiermann, W Jakisch, C Tulusan, AH Kaufmann, M
Citation: G. Von Minckwitz et al., Preoperative chemotherapy in breast cancer, ZBL CHIR, 123, 1998, pp. 138-141
Risultati: 1-8 |